Performance and functional outcome of endoscopic extraperitoneal radical prostatectomy in relation to obesity: an assessment of 500 patients

BJU International
Evangelos LiatsikosJens-Uwe Stolzenburg

Abstract

To investigate the impact of obesity on the performance and functional outcome of endoscopic extraperitoneal radical prostatectomy (EERPE). We retrospectively examined 500 patients treated with EERPE; they were categorized into three groups according to the World Health Organization classification of obesity: normal weight (body mass index, BMI, <25.0 kg/m(2)), overweight (25.0-29.9 kg/m(2)) and obese (30.0 kg/m(2)). The database of our institution was reviewed and perioperative data evaluated. The functional data were collected through questionnaires before and after EERPE and analysed statistically. The age, prostate size and preoperative PSA level were similar in all three groups. The mean (sd) BMI was 27 (3.3) kg/m(2), with 26.8%, 56.6% and 16.6% of the patients classed as normal, overweight and obese, respectively. A pelvic lymph node dissection and nerve-sparing was done in 218 and 123 patients, respectively. There was no statistically significance difference in the number of patients in each group who had previous procedures. Obese patients had a significantly higher American Society of Anesthesiologists score. The mean operative duration for all patients was 149 min; there was a statistically significant difference in d...Continue Reading

References

Mar 5, 1997·Journal of the National Cancer Institute·S O AnderssonO Nyrén
Mar 25, 2000·American Journal of Epidemiology·A G SchuurmanP A van den Brandt
Jun 29, 2002·World Journal of Urology·Jens-Uwe StolzenburgWolfgang Dorschner
Aug 21, 2003·Journal of the National Cancer Institute·Edward GiovannucciWalter C Willett
Aug 30, 2003·Urology·Judd Boczko, Arnold Melman
Dec 24, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher L AmlingDavid G McLeod
Jul 13, 2004·The Journal of Urology·Stephen J FreedlandUNKNOWN Search Database Study Group
Jan 12, 2005·The Journal of Urology·James A BrownDouglas M Dahl
Feb 15, 2005·Urology·Jens-Uwe StolzenburgMichael C Truss
Apr 19, 2005·Urology·Thomas E AhleringDouglas W Skarecky
May 21, 2005·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·V Pudel, T Ellrott
Jun 14, 2005·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·H Hauner
Sep 8, 2005·The Journal of Urology·Jens-Uwe StolzenburgMichael C Truss
Jan 18, 2006·Urology·Jens-Uwe StolzenburgEvangelos N Liatsikos
Aug 2, 2006·BJU International·Christopher G EdenDaniel A Moon

❮ Previous
Next ❯

Citations

Dec 20, 2011·Asian Journal of Andrology·Jens-Uwe StolzenburgEvangelos Liatsikos
Jan 30, 2010·Journal of Endourology·Ioannis VarkarakisCharalambos Deliveliotis
Nov 24, 2011·Prostate Cancer·Jennifer YatesIhor Sawczuk
Aug 29, 2012·Urology·Roger Valdivieso O'DonovaKevin C Zorn
Oct 30, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A OberbachJ Neuhaus
Jul 4, 2009·Expert Review of Medical Devices·Gerald Y TanAshutosh K Tewari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.